Monitoring der Progression von geografischer Atrophie in der optischen Kohärenztomographie

Published

2023

Audience

Therapeutic Area

Content Type

AI Generated Summary*

German-language overview from a Vienna group arguing that optical coherence tomography (OCT) with AI-based analysis suits monitoring of geographic atrophy as the first therapy nears approval. Manually annotated OCT volumes covered 100 routine patients and 113 from the phase 2 FILLY pegcetacoplan trial (11,074 B-scans); lesion areas on OCT and fundus autofluorescence correlated at 0.97. Treated patients lost retinal pigment epithelium (RPE) more slowly than untreated ones (p=0.014), as did photoreceptors (p=0.017), and photoreceptor loss exceeded RPE loss (p<0.001). Automated segmentation reached Dice values above 0.9 for RPE loss and 0.8 for photoreceptor loss. High baseline photoreceptor/RPE loss ratio flagged faster growth (p=0.006) and reportedly better response; heat maps showed quicker progression near the fovea and where photoreceptors were thinner.

*This summary was generated by AI and is published unedited. Oku does not alter these summaries. It may contain errors or omissions and is provided for general informational purposes only. Oku does not guarantee its accuracy, completeness, or reliability. For authoritative information, please refer to the original, peer-reviewed article.

At a glance

Authors
Ursula Schmidt-Erfurth; Julia Mai; Gregor S. Reiter; Sophie Riedl; Dmitrii Lachinov; Wolf-Dieter Vogl; Hrvoje Bogunovic
Publication
Die Ophthalmologie
Keywords
Geographic Atrophy, Tomography, Optical Coherence Tomography, Artificial Intelligence, Fluorescein Angiography, Retinal Pigment Epithelium, Disease Progression, Complement Inhibition
Year
2023
View primary source

This is the evidence

See where we take it next

Join the Network